Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

chronic neurovisceral acid sphingomyelinase deficiency News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A new study highlights the use of multiplex MSMS measurement of lysosomal enzymes for the incidental diagnosis of acid sphingomyelinase deficiency in patients being evaluated for Gaucher disease. This method could enhance diagnostic accuracy and patient management.

A recent case study highlights the complexities of acid sphingomyelinase deficiency (ASMD) in an asplenic patient, presenting severe interstitial lung disorder. This case underscores the need for further research into the respiratory complications associated with ASMD.

A single-center study in Taiwan reports significant improvements in quality of life and general functions for pediatric patients with acid sphingomyelinase deficiency after treatment with olipudase alfa. This research highlights the potential benefits of this therapy in managing the disease.

A post hoc analysis reveals that diffusing lung capacity for carbon monoxide significantly impacts mortality risk in patients with acid sphingomyelinase deficiency (ASMD). This study provides new insights into the respiratory complications associated with ASMD.

Not rare diseases news,news about your rare disease.

Earlier

A new study highlights the use of multiplex MSMS measurement of lysosomal enzymes for the incidental diagnosis of acid sphingomyelinase deficiency in patients being evaluated for Gaucher disease. This method could enhance diagnostic accuracy and patient management.

A recent case study highlights the complexities of acid sphingomyelinase deficiency (ASMD) in an asplenic patient, presenting severe interstitial lung disorder. This case underscores the need for further research into the respiratory complications associated with ASMD.

A single-center study in Taiwan reports significant improvements in quality of life and general functions for pediatric patients with acid sphingomyelinase deficiency after treatment with olipudase alfa. This research highlights the potential benefits of this therapy in managing the disease.

A post hoc analysis reveals that diffusing lung capacity for carbon monoxide significantly impacts mortality risk in patients with acid sphingomyelinase deficiency (ASMD). This study provides new insights into the respiratory complications associated with ASMD.

Not rare diseases news,
news about your rare disease.